Eliminating Structural Barriers: The Impact of Unrestricted Access on Hepatitis C Treatment Uptake Among People Living With Human Immunodeficiency Virus

BACKGROUND: High costs of direct-acting antivirals (DAAs) have led health-care insurers to limit access worldwide. Using a natural experiment, we evaluated the impact of removing fibrosis stage restrictions on hepatitis C (HCV) treatment initiation rates among people living with human immunodeficien...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Infect Dis
Autors principals: Saeed, Sahar, Strumpf, Erin, Moodie, Erica E M, Wong, Leo, Cox, Joseph, Walmsley, Sharon, Tyndall, Mark, Cooper, Curtis, Conway, Brian, Hull, Mark, Martel-Laferriere, Valerie, Gill, John, Wong, Alexander, Vachon, Marie-Louise, Klein, Marina B
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Articles and Commentaries
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7353326/
https://ncbi.nlm.nih.gov/pubmed/31504327
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz833
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars